Abstract |
Endothelial-mediated dilations to selective P2Y1 and P2Y2 purinoceptor agonists [2-methylthioadenosine triphosphate (2MeS-ATP) and uridine 5'-triphosphate ( UTP), respectively] were evaluated in middle cerebral arteries (MCAs) of rats after 2 h of ischemia followed by 24 h of reperfusion (I/R). MCAs were harvested, pressurized to 85 mmHg, and luminally perfused. 2MeS-ATP, which dilates by the synthesis and release of nitric oxide (NO), had significantly reduced maximum dilations following I/R. Reduced smooth muscle sensitivity to NO may explain the reduced dilation to 2MeS-ATP. In contrast, the dilations elicited by UTP were potentiated in that the concentration of agonist necessary to produce one-half of the maximum dilation was reduced by 75%. The potentiated dilation to UTP was the result of an endothelial factor having all the characteristics of the endothelium-derived hyperpolarizing factor ( EDHF). That is, it was neither NO nor a cyclooxygenase metabolite, and its actions involved calcium-activated potassium channels and smooth muscle hyperpolarization. We conclude that the effect of I/R on endothelial-mediated dilations depends on the receptor system and the mechanism of dilation. Dilations elicited by 2MeS-ATP were attenuated, while dilations UTP were potentiated due to the upregulation of the EDHF mechanism.
|
Authors | S P Marrelli, A Khorovets, T D Johnson, W F Childres, R M Bryan Jr |
Journal | The American journal of physiology
(Am J Physiol)
Vol. 276
Issue 1
Pg. H33-41
(01 1999)
ISSN: 0002-9513 [Print] United States |
PMID | 9887014
(Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
|
Chemical References |
- P2ry1 protein, rat
- P2ry2 protein, rat
- Receptors, Purinergic P2
- Receptors, Purinergic P2Y1
- Receptors, Purinergic P2Y2
- Nitric Oxide
|
Topics |
- Animals
- Brain Ischemia
(physiopathology)
- Cerebral Arteries
(physiopathology)
- Cricetinae
- Male
- Nitric Oxide
(metabolism)
- Rats
- Rats, Long-Evans
- Receptors, Purinergic P2
(physiology)
- Receptors, Purinergic P2Y1
- Receptors, Purinergic P2Y2
- Reperfusion Injury
(physiopathology)
- Vasodilation
(physiology)
- Vasomotor System
(physiopathology)
|